ABCI21 (AT5G02260) is part of a trio of ABCI subfamily proteins (ABCI19, ABCI20, ABCI21) in Arabidopsis thaliana. Key characteristics include:
Function: Modulates cytokinin response during early seedling development .
Regulation: Expression of ABCI20 and ABCI21 is induced by light in a HY5-dependent manner .
Genetic Interaction: Triple (abci19 abci20 abci21) and double (abci20 abci21) knockout mutants exhibit hypersensitivity to exogenous cytokinin, but not to auxin, ABA, GA, ACC, or BL .
While no ABCI21-specific antibody is described in the provided sources, insights from ABCI20 antibody development and general antibody engineering principles suggest potential strategies:
Hypersensitivity Phenotype: abci20 abci21 double mutants show enhanced growth retardation under cytokinin treatment, indicating redundant roles in cytokinin homeostasis .
Tissue-Specific Expression: ABCI21 is expressed in young seedlings, with transcript levels influenced by HY5-mediated light signaling .
If developed, an ABCI21 antibody could enable:
Localization Studies: Subcellular tracking via immunofluorescence or immunohistochemistry.
Protein-Protein Interaction Analysis: Co-immunoprecipitation (Co-IP) to identify binding partners.
Quantitative Assays: Western blotting to measure ABCI21 expression under varying conditions (e.g., light/dark cycles, hormone treatments).
Antigen Specificity: Designing epitopes unique to ABCI21 to avoid cross-reactivity with ABCI19/20.
Functional Validation: Linking antibody-based detection to phenotypic outcomes in mutant lines.
Comparative Studies: Leveraging antibodies for ABCI19/20/21 to dissect their individual vs. collective roles in cytokinin signaling.
ABCI21 is a member of the ABC transporter family in plants, specifically classified as part of the ABCI subfamily. It functions as a plasma membrane-localized ABC transporter involved in IAA (indole-3-acetic acid) transport in an outward direction. Studies have demonstrated that ABCI21 transports auxin less efficiently than naphthalene acetic acid (NAA), indicating substrate specificity . More significantly, ABCI21 interacts with ABCI19 and ABCI20 to form a protein complex at the endoplasmic reticulum membrane, where they collectively function to modulate cytokinin response during early seedling development. Light regulates the expression of these proteins through the transcription factor ELONGATED HYPOCOTYL 5 (HY5) .
Commercial ABCI21 antibodies show varying specificity profiles depending on the immunogen used for production. Currently available antibodies demonstrate reactivity with Arabidopsis thaliana, while some cross-react with related species like Brassica rapa and Brassica napus . This cross-reactivity reflects the conservation of ABCI21 protein structure across these plant families. When selecting an antibody for your research, consider whether you need species-specific detection or cross-reactivity with multiple plant species, as this will impact experimental design and interpretation.
ABCI21 antibodies are typically supplied in lyophilized form and require careful storage to maintain functionality. Storage recommendations include:
Using a manual defrost freezer to avoid temperature fluctuations
Avoiding repeated freeze-thaw cycles which can degrade antibody performance
Immediate storage at recommended temperatures upon receipt
The product is typically shipped at 4°C but should be stored according to manufacturer specifications
Following these guidelines ensures optimal antibody performance and extends shelf-life for research applications.
When using ABCI21 antibodies for Western blot applications, follow this optimized protocol:
Extract total protein using a buffer containing 50 mM Tris-HCl pH 8, 10 mM KCl, 10 mM MgCl₂, 1 mM EDTA, 20% glycerol (v/v), 0.25% Triton X-100 (v/v), with protease inhibitors
Separate proteins by SDS-PAGE using 10-12% gels for optimal resolution
Transfer to PVDF or nitrocellulose membranes using standard transfer conditions
Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature
Incubate with ABCI21 antibody at 1:1000-1:5000 dilution (optimize for your specific antibody) overnight at 4°C
Wash 3-5 times with TBST
Incubate with appropriate HRP-conjugated secondary antibody
Visualize using chemiluminescence detection
This methodology has been adapted from similar approaches used for ABCI20 antibodies in plant research . When troubleshooting Western blot issues, consider adjusting antibody concentrations, incubation times, or washing stringency.
For effective immunoprecipitation of ABCI21 and associated proteins:
Extract total proteins from plant tissues using extraction buffer (50 mM Tris-HCl pH 8, 10 mM KCl, 10 mM MgCl₂, 1 mM EDTA, 20% Glycerol, 0.25% Triton X-100 with protease inhibitors)
Incubate total protein extracts with anti-ABCI21 antibody overnight at 4°C
Add affinity resin (such as Affi-Gel 15) and incubate overnight at 4°C
Place the mixture in chromatography columns
Rinse sequentially with increasing NaCl concentration buffers (100 mM, 200 mM, 500 mM, and 1 M NaCl/Tris-HCl buffers)
Elute ABCI21 and associated proteins using an elution buffer containing 8 M Urea, 0.1 M NaH₂PO₄ pH 8, 50 mM Tris-HCl pH 8
This protocol has been adapted from successful approaches used with related ABCI proteins and allows for isolation of ABCI21 complexes for downstream analysis .
Custom antibody generation against ABCI21 can be approached through peptide antigen design:
Select a unique, accessible region of the ABCI21 protein (regions between 310-330 amino acids have proven successful for related proteins)
Synthesize peptide antigens representing this region
Conjugate peptides to carrier proteins (KLH or BSA)
Immunize rabbits with multiple boosts (typically 4 immunizations)
Collect serum and purify antibodies using affinity chromatography with Affi-Gel 15 resin
Validate antibody specificity using both wild-type and knockout mutant samples
This approach mirrors the successful generation of anti-ABCI20 antibodies, which used the peptide antigen RTEESRVTGDPARMLN (amino acids 311-326) . For ABCI21, identify unique epitopes using sequence alignment and structural prediction tools to ensure specificity.
To investigate protein-protein interactions involving ABCI21:
Co-immunoprecipitation (Co-IP):
Use anti-ABCI21 antibodies to pull down the protein complex
Analyze co-precipitated proteins by mass spectrometry or Western blotting with antibodies against suspected interaction partners (especially ABCI19 and ABCI20)
Proximity labeling:
Generate fusion constructs of ABCI21 with biotin ligase (BioID or TurboID)
Express in plant cells to biotinylate proteins in close proximity
Purify biotinylated proteins and identify by mass spectrometry
Fluorescence microscopy:
Use fluorescently-tagged anti-ABCI21 antibodies in combination with antibodies against other proteins
Analyze co-localization using confocal microscopy
Research has demonstrated that ABCI19, ABCI20, and ABCI21 interact with each other to form a large protein complex at the ER membrane, regulating cytokinin response . These techniques can further elucidate the composition and dynamics of this complex.
For investigating ABCI21 subcellular localization:
Immunofluorescence microscopy:
Fix plant cells with 4% paraformaldehyde
Permeabilize with 0.1% Triton X-100
Block with 3% BSA
Incubate with anti-ABCI21 primary antibody and fluorescently-labeled secondary antibody
Co-stain with organelle markers (BiP:RFP for ER)
Analyze using confocal microscopy
Subcellular fractionation:
Fractionate plant cells into membrane and soluble components
Further separate membrane fractions (plasma membrane, ER, Golgi, etc.)
Analyze fractions by Western blotting with anti-ABCI21 antibody
Compare with known organelle marker proteins
Transient expression systems:
Clone ABCI21 in fusion with fluorescent proteins (similar to approaches used for ABCI21:RFP)
Express in tobacco leaves via Agrobacterium infiltration
Observe localization 48 hours post-infiltration
Co-express with organelle markers for co-localization studies
Research has established that ABCI21 forms a complex with ABCI19 and ABCI20 at the ER membrane, challenging earlier assumptions about exclusive plasma membrane localization .
To investigate ABCI21's role in cytokinin response:
Immunoblotting analysis of ABCI21 protein levels:
Treat plants with various concentrations of cytokinins (trans-zeatin)
Extract proteins at different time points
Quantify ABCI21 protein levels via Western blotting
Compare with cytokinin response markers
Chromatin immunoprecipitation (ChIP):
Using antibodies against HY5 (transcription factor)
Analyze binding to ABCI21 promoter regions containing HY5 binding motifs
Correlate with light conditions and cytokinin treatment
Immunohistochemistry:
Use anti-ABCI21 antibodies on tissue sections
Compare expression patterns in wild-type vs. cytokinin signaling mutants
Analyze developmental regulation in seedlings
Research has established that abci19 abci20 abci21 triple knockout and abci20 abci21 double knockout seedlings exhibit hypersensitive growth retardation in response to exogenous cytokinin, indicating these proteins negatively regulate cytokinin responses . Antibody-based approaches can help elucidate the molecular mechanisms behind this phenotype.
| Issue | Possible Causes | Solutions |
|---|---|---|
| Low signal in Western blot | Insufficient protein, low antibody affinity, degraded antibody | Increase protein loading (50-100 μg), optimize antibody dilution, use fresh antibody aliquots |
| High background | Non-specific binding, insufficient blocking, contaminated buffers | Increase blocking time/concentration, use highly purified antibody, prepare fresh buffers |
| Multiple bands | Cross-reactivity, protein degradation, post-translational modifications | Validate with knockout controls, add protease inhibitors, compare with predicted MW |
| No signal in immunoprecipitation | Low abundance protein, antibody epitope masked in native conditions | Scale up starting material, try different antibody targeting another epitope |
| False positives in localization | Fixation artifacts, non-specific binding | Include negative controls, validate with multiple techniques |
When troubleshooting ABCI21 antibody applications, remember that expression levels vary throughout development, with higher expression in young seedlings and becoming more root-selective at 14 days after sowing .
When interpreting antibody specificity using knockout mutants:
Western blot analysis:
Compare protein extracts from wild-type and abci21 knockout plants
A specific antibody should show a band at the expected molecular weight in wild-type samples that is absent in knockout samples
Any remaining bands in knockout samples represent non-specific binding
Immunolocalization validation:
Perform parallel immunostaining on wild-type and knockout tissues
Specific signals should be absent in the knockout
Remaining signals indicate non-specific binding or cross-reactivity
Quantitative considerations:
Evaluate background-to-signal ratio in both genotypes
Calculate specificity index (ratio of wild-type to knockout signal intensity)
Values >10 generally indicate good specificity
When working with ABCI21, consider using established knockout lines like SALK_064144, which has been verified as a null mutant by RT-PCR . This approach is particularly important because ABCI21 functions redundantly with ABCI19 and ABCI20, and antibody cross-reactivity between these related proteins must be carefully assessed.
When analyzing the ABCI19/20/21 protein family:
Expression pattern analysis:
Compare tissue-specific expression using qRT-PCR data
Note that ABCI19 transcript levels are much lower than ABCI20 and ABCI21
All three genes show primarily root-selective expression at 14 days after sowing
Expression data table (relative expression levels):
| Gene | Shoot (3-8 DAS) | Root (3-8 DAS) | Shoot (14 DAS) | Root (14 DAS) |
|---|---|---|---|---|
| ABCI19 | Low | Low | Very low | Low-moderate |
| ABCI20 | Moderate | Moderate | Low | High |
| ABCI21 | Moderate | Moderate | Low | High |
Phenotypic comparison:
Single abci21 knockouts may not show strong phenotypes due to redundancy
Double knockouts (abci20 abci21) show hypersensitivity to cytokinin
Triple knockouts (abci19 abci20 abci21) show similar but not enhanced phenotypes compared to double knockouts
Protein complex analysis:
Use antibodies against all three proteins for reciprocal co-immunoprecipitation
Compare binding partners and complex composition
Analyze subcellular localization of individual proteins vs. the complex
Research has established that these three ABCI proteins form a complex at the ER membrane and function together to modulate cytokinin response. Their expression is regulated by light through the transcription factor HY5, with ABCI20 and ABCI21 showing light-induced expression in a HY5-dependent manner .
ABCI21 antibodies can advance our understanding of hormone transport through:
Transporter activity assays:
Immunopurify ABCI21 complexes from various developmental stages
Reconstitute in liposomes to measure transport activity
Compare affinities for different hormones (IAA vs. cytokinins)
Correlate with in vivo phenotypes
Structural studies:
Use antibodies to purify native ABCI21 complexes
Perform cryo-EM analysis to determine structure
Map functional domains and interaction surfaces
Design specific inhibitors based on structural information
Systems biology approaches:
Immunoprecipitate ABCI21 complexes from plants under various environmental conditions
Identify condition-specific interaction partners
Map hormone transport networks and regulatory mechanisms
Current research has established that ABCI21 is involved in IAA transport in an outward direction and also functions in modulating cytokinin response . Future research using ABCI21 antibodies can help reconcile these findings and establish a comprehensive model of how ABC transporters regulate hormone homeostasis in plants.
Emerging methodologies that could enhance ABCI21 antibody applications include:
Single-molecule imaging:
Develop high-affinity, minimally disruptive antibody fragments (Fabs, nanobodies)
Label with photostable fluorophores
Track single ABCI21 molecules in living cells
Analyze dynamics, clustering, and transport activity
Proximity-dependent labeling:
Engineer ABCI21 fusions with proximity labeling enzymes
Use antibodies to purify labeled proteins
Map the dynamic ABCI21 interactome at different developmental stages
Identify transient interactions during hormone signaling
Antibody-based biosensors:
Develop FRET-based sensors using ABCI21 antibodies
Monitor conformational changes during transport
Measure hormone binding in real-time
Correlate with physiological responses
These innovative approaches could overcome current limitations in studying membrane-bound transporters and provide unprecedented insights into ABCI21 function in hormone transport and signaling.
ABCI21 antibodies can help address several unresolved questions:
Subcellular localization discrepancy:
Functional redundancy analysis:
Compare protein levels of ABCI19/20/21 in single, double, and triple mutants
Investigate compensatory upregulation
Correlate protein levels with phenotypic severity
Identify unique vs. redundant functions
Hormone specificity question:
ABCI21 is implicated in both auxin transport and cytokinin response
Use antibodies to purify native complexes
Perform binding assays with different hormones
Compare complex composition in response to different hormones
Current research shows that abci21 knockout plants exhibit hypersensitivity to cytokinin but not to other major plant hormones including auxin , which seems contradictory to its reported role in IAA transport . Antibody-based approaches can help resolve this apparent contradiction by elucidating the precise molecular mechanisms linking ABCI21 to these hormone pathways.
When selecting and validating ABCI21 antibodies for research:
Match antibody to application:
For Western blotting: Select antibodies raised against denatured epitopes
For immunoprecipitation: Choose antibodies recognizing native conformations
For immunofluorescence: Test multiple antibodies for specificity in fixed tissues
Comprehensive validation strategy:
Genetic validation: Test on abci21 null mutants (e.g., SALK_064144)
Biochemical validation: Peptide competition assays
Cross-reactivity assessment: Test on related proteins (ABCI19, ABCI20)
Application-specific validation: Optimize conditions for each technique
Documentation requirements:
Record complete antibody information (source, catalog number, lot)
Document all validation experiments
Include knockout controls in publications
Report optimization parameters
Following these best practices ensures reproducible research and enables meaningful comparison of results across different studies investigating ABCI transporters in plant development.
When using ABCI21 antibodies for developmental research:
Developmental timing considerations:
ABCI21 expression varies throughout development
Expression is detected in both shoots and roots in early seedling stages (3-8 days)
Expression becomes primarily root-selective by 14 days after sowing
Design sampling strategies accordingly
Tissue-specific analysis:
Use tissue-specific extraction methods to enrich for ABCI21
Compare with expression patterns from promoter:GUS studies
Consider cell-type specific variations in protein levels
Environmental conditions:
ABCI21 expression is regulated by light in a HY5-dependent manner
Standardize light conditions when comparing samples
Document all growth conditions in detail
These methodological considerations ensure that ABCI21 antibody applications yield physiologically relevant results that can be interpreted in the context of plant development and environmental responses.